Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
5.15
+0.41 (8.65%)
At close: Sep 26, 2025, 4:00 PM EDT
4.710
-0.440 (-8.54%)
After-hours: Sep 26, 2025, 7:56 PM EDT
Bio Green Med Solution Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.01 | 0.04 | 0.42 | - | - | - | |
| Revenue Growth (YoY) | -87.50% | -89.76% | - | - | - | - | |
| Gross Profit | 0.01 | 0.04 | 0.42 | - | - | - | |
| Selling, General & Admin | 7.65 | 5.39 | 6.72 | 7.38 | 7.46 | 5.88 | |
| Research & Development | 2.72 | 6.66 | 19.16 | 20.27 | 14.93 | 4.76 | |
| Operating Expenses | 10.37 | 12.05 | 25.87 | 27.66 | 22.39 | 10.64 | |
| Operating Income | -10.36 | -12 | -25.45 | -27.66 | -22.39 | -10.64 | |
| Interest & Investment Income | 0.05 | 0.01 | 0.27 | 0.21 | 0.02 | 0.04 | |
| Currency Exchange Gain (Loss) | -0.07 | -0.05 | -0.41 | 0.23 | 0.04 | 0.02 | |
| Other Non Operating Income (Expenses) | 0.01 | 0.05 | 0.05 | 1.3 | 0.14 | 0.89 | |
| EBT Excluding Unusual Items | -10.37 | -11.99 | -25.55 | -25.92 | -22.19 | -9.68 | |
| Pretax Income | -5.42 | -11.99 | -25.55 | -25.92 | -22.19 | -9.68 | |
| Income Tax Expense | 0.99 | -0.78 | -3 | -4.72 | -3.73 | -1.24 | |
| Earnings From Continuing Operations | -6.41 | -11.21 | -22.56 | -21.2 | -18.46 | -8.45 | |
| Net Income | -6.41 | -11.21 | -22.56 | -21.2 | -18.46 | -8.45 | |
| Preferred Dividends & Other Adjustments | 0.02 | - | 0.2 | 0.2 | 0.2 | 3.98 | |
| Net Income to Common | -6.43 | -11.21 | -22.76 | -21.4 | -18.66 | -12.42 | |
| Shares Outstanding (Basic) | 2 | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 2 | 0 | - | - | - | - | |
| EPS (Basic) | -4.06 | -502.46 | - | - | - | - | |
| EPS (Diluted) | -4.06 | -502.46 | - | - | - | - | |
| Free Cash Flow | -8.73 | -7.99 | -16.12 | -20.83 | -18.57 | -8.03 | |
| Free Cash Flow Per Share | -5.51 | -358.07 | - | - | - | - | |
| Gross Margin | 100.00% | 100.00% | 100.00% | - | - | - | |
| Operating Margin | -103580.00% | -27916.28% | -6060.24% | - | - | - | |
| Profit Margin | -64280.00% | -26074.42% | -5418.10% | - | - | - | |
| Free Cash Flow Margin | -87260.00% | -18581.40% | -3837.62% | - | - | - | |
| EBITDA | -10.36 | -12 | -25.42 | -27.62 | -22.35 | -10.62 | |
| D&A For EBITDA | 0 | 0.01 | 0.03 | 0.03 | 0.04 | 0.02 | |
| EBIT | -10.36 | -12 | -25.45 | -27.66 | -22.39 | -10.64 | |
| Revenue as Reported | 0.01 | 0.04 | 0.42 | - | - | - | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.